Real‐world use of continuous glucose monitoring in people with type 2 diabetes and chronic kidney disease or on dialysis
Diabetic Medicine · 2026
DOI: 10.1111/dme.70174 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetic Medicine, 2026. Verfasst von Patrick McGown und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Imperial College London NHS Trust, London, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic, Blood Glucose Self-Monitoring, Blood Glucose. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Continuous glucose monitoring (CGM) has become the standard of care for people with type 1 diabetes (T1D) and some people with type 2 diabetes (T2D). However, there is a lack of data regarding CGM use in people with T2D and chronic kidney disease (CKD), who are at increased risk of hypoglycaemia. We assess the use of CGM and glucose outcomes in this cohort.
Methods
Retrospective, observational analysis of adults on CGM attending a tertiary diabetes renal clinic between January 2023 and September 2024. People with T2D on multiple daily insulin injections (defined as 2 or more insulin injections per day) and CKD stage 3–5 (eGFR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diabetes and Endocrinology, Imperial College London NHS Trust, London, UK.
- Department of Renal Medicine, Imperial College London NHS Trust, London, UK.
- Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
ORCID-Profile: Parizad Avari
Zitieren
APA
McGown, P., Papanikolaou, N., El-Taraboulsi, J., Britton, C., Iqtidar, J., Chaudhry, K., Ng, S., Jethwa, K., Patel, J., Reed, J., Reddy, M., Leelarathna, L., Frankel, A. H., Uduku, C., & Avari, P. (2026). Real‐world use of continuous glucose monitoring in people with type 2 diabetes and chronic kidney disease or on dialysis. Diabetic Medicine. https://doi.org/10.1111/dme.70174
Vancouver
McGown P, Papanikolaou N, El-Taraboulsi J, Britton C, Iqtidar J, Chaudhry K, et al. Real‐world use of continuous glucose monitoring in people with type 2 diabetes and chronic kidney disease or on dialysis. Diabetic Medicine. 2026. doi:10.1111/dme.70174
BibTeX
@article{McGown2026,
author = {McGown, Patrick and Papanikolaou, Nikoleta and El-Taraboulsi, Jasmine and Britton, Clemency and Iqtidar, Javeria and Chaudhry, Khuram and Ng, Shiyan and Jethwa, Kishan and Patel, Jagvi and Reed, Jo and Reddy, Monika and Leelarathna, Lalantha and Frankel, Andrew H and Uduku, Chukwuma and Avari, Parizad},
title = {Real‐world use of continuous glucose monitoring in people with type 2 diabetes and chronic kidney disease or on dialysis},
journal = {Diabetic Medicine},
year = {2026},
doi = {10.1111/dme.70174}
}
EUVIMED